Results 161 to 170 of about 184,119 (211)
Therapeutic Cancer Vaccines Targeting Molecules Associated with Tumor Angiogenesis
, 2014 Julia Femel
openalex +1 more source
Engineered Genetic Circuits Activated by Bezafibrate Improve ESC-Based TAA Cancer Vaccine Efficacy and PD-L1 Nanobody Therapy. [PDF]
Adv Sci (Weinh)Jin M, Liu S, Zhan M, Huang JD.
europepmc +1 more source
Modification of Fc-fusion protein structures to enhance efficacy of cancer vaccine in plant expression system. [PDF]
Plant Biotechnol JLim S +6 more
europepmc +1 more source
Unlocking cancer vaccine potential: What are the key factors? [PDF]
Hum Vaccin ImmunotherGrant M +9 more
europepmc +1 more source
TGF-β and IL-12 conversely orchestrate the formation of CD103<sup>+</sup> CD8 tumor-resident memory T cells to regulate response to therapeutic cancer vaccine. [PDF]
iScienceCorgnac S +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematology/Oncology Clinics of North America, 2001
Attempts to generate an anticancer immune response in vivo in patients with cancer have taken several forms. Although to date there have been relatively few published studies describing the effects of the approach in hematologic malignancy, that circumstance is expected to change rapidly during the next few years. In solid tumors, it is not known which,
R F, Rousseau +3 more
+7 more sources
Attempts to generate an anticancer immune response in vivo in patients with cancer have taken several forms. Although to date there have been relatively few published studies describing the effects of the approach in hematologic malignancy, that circumstance is expected to change rapidly during the next few years. In solid tumors, it is not known which,
R F, Rousseau +3 more
+7 more sources
Seminars in Oncology Nursing, 2003
To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments.Research studies, review articles, book chapters, personal communications.Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination.
Paula M, Muehlbauer +1 more
+6 more sources
To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments.Research studies, review articles, book chapters, personal communications.Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination.
Paula M, Muehlbauer +1 more
+6 more sources
Nature Reviews Cancer, 2021
Therapeutic cancer vaccines have undergone a resurgence in the past decade. A better understanding of the breadth of tumour-associated antigens, the native immune response and development of novel technologies for antigen delivery has facilitated improved vaccine design.
Saxena, M. +3 more
openaire +3 more sources
Therapeutic cancer vaccines have undergone a resurgence in the past decade. A better understanding of the breadth of tumour-associated antigens, the native immune response and development of novel technologies for antigen delivery has facilitated improved vaccine design.
Saxena, M. +3 more
openaire +3 more sources
Current Protocols in Human Genetics, 1997
AbstractThis unit describes the use of retroviral vectors that can be successfully employed for gene transfer into both primary tumor cultures and established cell lines. The unit includes procedures for assaying the stability of the vaccine following gene transfer.
T F, Greten, E M, Jaffee
openaire +5 more sources
AbstractThis unit describes the use of retroviral vectors that can be successfully employed for gene transfer into both primary tumor cultures and established cell lines. The unit includes procedures for assaying the stability of the vaccine following gene transfer.
T F, Greten, E M, Jaffee
openaire +5 more sources
Hematology/Oncology Clinics of North America, 2019
Cancer vaccines are a promising strategic approach within the rapidly growing field of immuno-oncology. Therapeutic cancer vaccines are distinct from prophylactic vaccines and vary by both target antigen and vaccine platform. There are currently 3 FDA-approved therapeutic cancer vaccines: intravesical BCG live, sipuleucel-T, and T-VEC.
Peter J, DeMaria, Marijo, Bilusic
openaire +2 more sources
Cancer vaccines are a promising strategic approach within the rapidly growing field of immuno-oncology. Therapeutic cancer vaccines are distinct from prophylactic vaccines and vary by both target antigen and vaccine platform. There are currently 3 FDA-approved therapeutic cancer vaccines: intravesical BCG live, sipuleucel-T, and T-VEC.
Peter J, DeMaria, Marijo, Bilusic
openaire +2 more sources